Effect of Histone and Histone-RNA Complexes on the Disease Process of Murine Systemic Lupus Erythematosus

Abstract

Systemic lupus crythematosus (SLE) is characterised by the production of a variety of autoantibodies against cell surface, nuclear and cytoplasmic antigens. The antigen or antigens responsible for the induction of this disease is/are unknown. We have analysed the antigenicity and pathogenicity of free histones and histones complexed with RNA in Balb/c, BIO Br, C57BL/6 and MRL-lpr/lpr mice by giving 1 μg and 25 μg of each antigen intraperitoncally in complete and incomplete Freund's adjuvant. The same number of control animals were injected with either adjuvant or PBS.

In the initial experiment we gave three doses of antigen at three weekly intervals. BIO Brown and C57BL/6 mice had no response to the antigens. Balb/c mice developed a mild transient antibody response against H1 histone, branched peptide of ubiquitinated H2A (peptide T4) and also against ssDNA. However in repeated experiments when the histone-RNA complex was injected into young MRL-lpr/lpr animals at two weekly intervals, a significantly increased antibody response was detected against H1, peptide T4 and some histone peptide residues (204–218 of H1, 1–20 and 65–85 of H2A, 1–25 of H2B, 1–21 of H3 and 1–29 of H4) compared to the control groups. Moreover, this group also showed elevated scrum anti-DNA antibody levels and early impairment of renal function assessed by the urine protein levels.

These experiments have demonstrated that there is a genetic variation in antibody responses against histones and histone-RNA complexes and that histone-RNA complexes exaggerate the disease in young MRL-lpr/lpr mice by inducing antibodies to basic regions of histones and other autoantigens.

Key Words:

• Systemic lupus erythematosus
• Autoantibodies
• Histones
• histone-RNA complexes